174 reports of this reaction
3.5% of all LEVONORGESTREL AND ETHINYL ESTRADIOL reports
#2 most reported adverse reaction
HEADACHE is the #2 most commonly reported adverse reaction for LEVONORGESTREL AND ETHINYL ESTRADIOL, manufactured by Teva Pharmaceuticals USA, Inc.. There are 174 FDA adverse event reports linking LEVONORGESTREL AND ETHINYL ESTRADIOL to HEADACHE. This represents approximately 3.5% of all 4,908 adverse event reports for this drug.
Patients taking LEVONORGESTREL AND ETHINYL ESTRADIOL who experience headache should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
HEADACHE is moderately reported among LEVONORGESTREL AND ETHINYL ESTRADIOL users, representing a notable but not dominant share of adverse events.
In addition to headache, the following adverse reactions have been reported for LEVONORGESTREL AND ETHINYL ESTRADIOL:
The following drugs have also been linked to headache in FDA adverse event reports:
HEADACHE has been reported as an adverse event in 174 FDA reports for LEVONORGESTREL AND ETHINYL ESTRADIOL. This does not prove causation, but indicates an association observed in post-market surveillance data.
HEADACHE accounts for approximately 3.5% of all adverse event reports for LEVONORGESTREL AND ETHINYL ESTRADIOL, making it one of the most commonly reported side effect.
If you experience headache while taking LEVONORGESTREL AND ETHINYL ESTRADIOL, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.